Drug Shortage Report for AMOXICILLIN
Report ID | 177581 |
Drug Identification Number | 02401541 |
Brand name | AMOXICILLIN |
Common or Proper name | Amoxicillin suspension |
Company Name | SIVEM PHARMACEUTICALS ULC |
Market Status | MARKETED |
Active Ingredient(s) | AMOXICILLIN |
Strength(s) | 250MG |
Dosage form(s) | GRANULES FOR SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 150 |
ATC code | J01CA |
ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2022-11-21 |
Estimated end date | 2023-06-01 |
Actual end date | 2023-03-03 |
Shortage status | Resolved |
Updated date | 2024-02-14 |
Company comments | Market shortage |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 4705 DOBRIN STREET SAINT-LAURENT, QUEBEC CANADA H4R 2P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2024-02-14 | English | Compare |
v7 | 2023-08-16 | French | Compare |
v6 | 2023-08-16 | English | Compare |
v5 | 2023-04-26 | French | Compare |
v4 | 2023-04-26 | English | Compare |
v3 | 2022-12-15 | English | Compare |
v2 | 2022-12-09 | French | Compare |
v1 | 2022-12-09 | English | Compare |
Showing 1 to 8 of 8